This comprehensive review examines the therapeutic potential of BPC 157, a stable gastric pentadecapeptide (GEPPPGKPADDAGLV, MW 1419), in treating various gastrointestinal (GI) disorders. BPC 157 is an anti-ulcer peptide that remains stable in human gastric juice and has demonstrated safety in clinical trials for inflammatory bowel disease (IBD) and wound
